The Tel Aviv Stock Exchange was fairly flat today. The Tel Aviv 25 Index rose 0.08%, to 1,458.99 points; the Tel Aviv 100 Index fell 0.07%, to 1,305.99 points; and the BlueTech Index fell 0.04%, to 312.11 points. The TelBond 20 corporate bond index fell 0.08%, to 324.90 points. Turnover totaled NIS 1.27 billion.
The Tel Aviv 25 Index rose 4.2% in September, and is up 9.75% year-to-date.
On the foreign exchange market, the representative shekel-dollar rate was set 0.244% higher, at NIS 3.6950/$, and the shekel-euro rate was set 0.709% lower, at NIS 4.6486/€.
Today's most heavily traded stock was Israel Chemicals, which rose 1.37%. Next in line was Teva, which fell 0.75%, followed by Mizrahi Tefahot, up 1.06%, Delek Group, up 2.43%, and Bank Leumi, down 0.4%.
Delek Group was one of today's main advancers, while the most notable decliners were Clal Insurance, down 2.71%, and IDB Development, down 4.18%.
Among technology stocks, Ceragon stood out with an 8.51% rise, following the announcement of orders worth over $50 million. Can-Fite BioPharma rose 3.8%, after announcing that it been granted a US patent on one of its products.
Published by Globes [online], Israel business news - www.globes-online.com - on September 30, 2014
© Copyright of Globes Publisher Itonut (1983) Ltd. 2014